Fineotex Chemical profit and loss

Latest FY26

Revenue: ₹772cr+44.8% on FY25
EBITDA: ₹135cr+5.9% on FY25
Net profit: ₹125cr+14.5% on FY25
EPS: ₹1.09−88.6% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,012	772	533	569	517	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	34.0	33.1	24.3	16.5	7.3
	1,046	805	558	586	524
	678	512	339	340	341
	9.6	18.1	3.0	14.1	1.3
	−18.0	−13.1	−14.1	−5.3	−2.7
	61.0	40.4	24.3	21.2	18.4
	1.3	1.4	1.1	1.3	0.8
	15.1	13.4	9.2	6.0	4.3
	113	79.8	54.2	50.6	46.8
	860	652	416	428	410
	169	135	127	148	113
	154	121	118	142	108
Profit
	186	153	141	158	115
	186	153	141	158	115
	38.4	26.5	29.3	34.8	24.2
	−0.3	1.5	2.7	1.8	1.0
	38.1	28.0	32.0	36.5	25.2
	148	125	109	121	89.6
	148	125	109	121	89.6
	0.3	0.2	−0.0	−0.2	0.0
	149	125	109	121	89.6
	122	109	108	120	88.3
	25.9	16.3	1.0	1.2	1.2
Per share
	₹3.32	₹1.09	₹9.53	₹10.82	₹7.97
	₹3.32	₹1.09	₹9.53	₹10.82	₹7.97
Other comprehensive income — detail
	0.3	0.2	−0.0	—	—
	−0.3	−0.2	0.0	—	—
	—	—	—	0.2	−0.0
	123	109	108	120	88.3
	25.9	16.3	1.0	1.2	1.2
Per share — as-filed variants
	₹3.32	₹1.09	₹9.53	₹10.82	₹7.97
	₹3.32	₹1.09	₹9.53	₹10.82	₹7.97
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	342	255	206	220	178
	33.8%	33.0%	38.6%	38.7%	34.4%
Adjusted (ex-exceptional items) — derived
	186	153	141	158	115
	148	125	109	121	89.6
	₹3.32	₹1.09	₹9.53	₹10.82	₹7.97

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

FCL₹51.19

Fineotex Chemical Limited

· Chemicals

Annual Quarterly₹ CrorePeersEPIGRAL YASHO GUJALKALI FOSECOIND VISHNU GALAXYSURF TATVA JUBLCPLMcap ₹5,961 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	517.0	569.0	533.3	772.2	1,011.8
Other Income	7.3	16.5	24.3	33.1	34.0
Total Income	524.3	585.5	557.6	805.3	1,045.8
Expenses
+ Cost of Materials Consumed	340.6	340.0	338.8	512.4	677.9
+ Purchases of Stock-in-Trade	1.3	14.1	3.0	18.1	9.6
+ Changes in Inventories	-2.7	-5.3	-14.1	-13.1	-18.0
+ Employee Benefit Expense	18.4	21.2	24.3	40.4	61.0
+ Finance Costs	0.8	1.3	1.1	1.4	1.3
+ Depreciation & Amortisation	4.3	6.0	9.2	13.4	15.1
+ Other Expenses	46.8	50.6	54.2	79.8	112.6
Total Expenses	409.5	427.9	416.4	652.3	859.5
EBITDA	112.6	148.4	127.2	134.7	168.7
EBIT	108.3	142.4	118.0	121.3	153.6
Profit
PBT before Exceptional Items	114.8	157.6	141.2	153.0	186.3
Pretax Income	114.8	157.6	141.2	153.0	186.3
+ Current Tax	24.2	34.8	29.3	26.5	38.4
+ Deferred Tax	1.0	1.8	2.7	1.5	-0.3
Tax Expense	25.2	36.5	32.0	28.0	38.1
Net Income	89.6	121.0	109.2	125.0	148.2
+ Net Income — Continuing Ops	89.6	121.0	109.2	125.0	148.2
+ Other Comprehensive Income	0.0	-0.2	-0.0	0.2	0.3
Total Comprehensive Income	89.6	120.8	109.2	125.2	148.5
Net Income to Common	88.3	119.8	108.2	108.8	122.3
Minority Interest	1.2	1.2	1.0	16.3	25.9
Per Share
Basic EPS	7.97	10.82	9.53	1.09	3.32
Diluted EPS	7.97	10.82	9.53	1.09	3.32
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.0	0.2	0.3
+ Tax on Items NOT to be Reclassified	—	—	0.0	-0.2	-0.3
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.2	—	—	—
Comprehensive Income — Owners of Parent	88.3	119.6	108.2	109.0	122.7
Comprehensive Income — Non-controlling Interests	1.2	1.2	1.0	16.3	25.9
Per Share — as-filed variants
Basic EPS — Continuing Operations	7.97	10.82	9.53	1.09	3.32
Diluted EPS — Continuing Operations	7.97	10.82	9.53	1.09	3.32
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	177.8	220.2	205.7	254.9	342.3
Gross Margin %	34.39	38.69	38.57	33.00	33.83
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	114.8	157.6	141.2	153.0	186.3
Net Income Adj (tax-effected)	89.6	121.0	109.2	125.0	148.2
EPS Adj	7.97	10.82	9.53	1.09	3.32
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	1.00	1.00
Paid Up Equity Capital	22.1	22.2	22.9	116.5	116.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.